Universidade Federal de Santa Catarina, Department of Surgery - Florianópolis (SC), Brazil.
Universidade Federal de Santa Catarina, School of Medicine - Florianópolis (SC), Brazil.
Arq Bras Cir Dig. 2023 Jul 17;36:e1747. doi: 10.1590/0102-672020230029e1747. eCollection 2023.
Asymptomatic cholelithiasis is a highly prevalent disease, and became more evident after the currently greater access to imaging tests. Therefore, it is increasingly necessary to analyse the risks and benefits of performing a prophylactic cholecystectomy.
To seek the best evidence in order to indicate prophylactic cholecystectomy or conservative treatment (clinical follow-up) in patients with asymptomatic cholelithiasis.
A systematic review was performed using the PubMed/Medline database, according to PRISMA protocol guidelines. The review was based on studies published between April 26, 2001 and January 07, 2022, related to individuals older than 18 years., The following terms/operators were used for search standardization: (asymptomatic OR silent) AND (gallstones OR cholelithiasis).
We selected 18 studies eligible for inference production after applying the inclusion and exclusion criteria. Also, the Tokyo Guideline (2018) was included for better clarification of some topics less or not addressed in these studies.
Most evidence point to the safety and feasibility of conservative treatment (clinical follow-up) of asymptomatic cholelithiasis. However, in post-cardiac transplant patients and those with biliary microlithiasis with low preoperative surgical risk, a prophylactic cholecystectomy is recommended. To establish these recommendations, more studies with better levels of evidence must be conducted.
无症状性胆石症是一种高发疾病,随着影像学检查的广泛应用,其发病率变得更加明显。因此,分析预防性胆囊切除术的风险和获益变得愈发必要。
寻求最佳证据,以确定无症状性胆石症患者行预防性胆囊切除术或保守治疗(临床随访)的适应证。
按照 PRISMA 协议指南,使用 PubMed/Medline 数据库进行系统评价。该综述基于 2001 年 4 月 26 日至 2022 年 1 月 7 日期间发表的、与 18 岁以上个体相关的研究。为了标准化检索,使用了以下术语/运算符:(无症状或无声)和(胆囊结石或胆石症)。
应用纳入和排除标准后,我们选择了 18 项适合推断生产的研究。此外,还纳入了 2018 年东京指南,以更好地阐明这些研究中较少或未涉及的一些主题。
大多数证据表明,无症状性胆石症的保守治疗(临床随访)是安全且可行的。然而,对于心脏移植后患者和术前手术风险较低的胆系微结石患者,建议行预防性胆囊切除术。为了建立这些建议,必须进行更多具有更高证据水平的研究。